EE486 Budget Impact Analysis of Cenobamate as Novel Adjunctive Treatment for FOS in Epilepsy Patients Inadequately Controlled With at Least Three Anti-Seizure Medications for the Belgian Healthcare Payer
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.729
https://www.valueinhealthjournal.com/article/S1098-3015(22)02933-3/fulltext
Title :
EE486 Budget Impact Analysis of Cenobamate as Novel Adjunctive Treatment for FOS in Epilepsy Patients Inadequately Controlled With at Least Three Anti-Seizure Medications for the Belgian Healthcare Payer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02933-3&doi=10.1016/j.jval.2022.09.729
First page :
Section Title :
Open access? :
No
Section Order :
10274